Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by inthnoon Nov 14, 2023 9:25pm
169 Views
Post# 35735922

RE:RE:RE:RE:RE:RE:Institutional investor

RE:RE:RE:RE:RE:RE:Institutional investor I gotta agree with Note on this one Canada fan as you always tout that you quote from pr's etc
YOu said you need something to read to comment so here you go.
https://ansonomics.com/about-anson-funds/


Anson is not a mutual fund company as hedge funds are privately held and generally not subject to the same rules of the securities commissions.

A lesson on a hedge fund.

What Is a Hedge Fund?

A hedge fund is a limited partnership of private investors whose money is managed by professional fund managers who use a wide range of strategies, including leveraging or trading of non-traditional assets, to earn above-average investment returns.

 

Hedge fund investment is often considered a risky alternative investment choice and usually requires a high minimum investment or net worth, often targeting wealthy clients.

And that is the tip of the iceberg as they openly say that they will short stocks that they feel are overpriced for gains.

From a search on Anson'''''Anson Funds is an investment management firm running a collection of privately-held onshore partnerships and offshore companies (hedge funds). We invest primarily in publicly-traded equity, debt, and derivative securities on a global basis. We have offices in Dallas and Toronto.

<< Previous
Bullboard Posts
Next >>